At 38 weeks of gestation, a woman with a previously unremarkable pregnancy was noted to have fetal tachycardia without obvious cause. Fetal echocardiography resulted in a presumptive diagnosis of fetal atrial flutter with a 2:1 block. The newborn resumed the same rhythm. The neonate underwent transesophageal incremental overdrive pacing. A normal sinus rhythm was restored. The infant had no recurrence to age 6 months.
1 7 weeks of gestation. As part of her visit, the fetal heart rate was auscultated and found to be greater than 200 bpm by Doppler. The patient's history was negative for febrile illness, cigarette smoking, recent caffeine intake, or the use of illicit drugs during her pregnancy. Her past medical history was negative for thyroid dysfunction.
During this pregnancy, her care had begun in the first trimester. An anatomical survey of her fetus at 19 weeks revealed no anomalies. She was noted to be A þ , RPR NR, Rubella immune, HBSAg negative, HIV negative, PPD negative, GBS negative, and GC and Chlamydia negative.
On her initial visit, she was noted to have a history of a childhood heart murmur that had never been symptomatic or required treatment. Past surgical history was negative. She denied use of cigarettes, alcohol, or illicit drugs. Her only medication during pregnancy was prenatal vitamins.
During her subsequent prenatal visits, auscultation of the fetal heart rate had been unremarkable. The remainder of her prenatal course had been without complication. Serial ultrasounds demonstrated appropriate interval growth of the fetus.
She was immediately directed to the antepartum testing unit for evaluation and possible admission. Further history revealed that her past obstetrical history was significant for a term birth in 1995 of a 6 lb 8 oz female, who was alive and well. Prior to that pregnancy, she had two elective terminations. Earlier in this year, NF had a pregnancy that resulted in a spontaneous abortion.
NF was admitted to labor and delivery after she had undergone both antepartum testing and fetal echocardiography. On ultrasound, there was no evidence of ascites, or pleural/pericardial effusions noted. The biophysical profile was 8/10 (NST was nonreactive). The amniotic fluid index was 14 cm and the estimated fetal weight was 3579 g. Fetal echocardiography demonstrated a ventricular heart rate of about 236 bpm. The atrial heart rate was noted to be 469 bpm. The ductus arteriosus Doppler velocimetry revealed variable peak systolic velocity waves. No structural cardiac defects were observed. Based upon these findings, the diagnosis of fetal atrial flutter with 2:1 block was made (Figures 1 and 2 ).
On admission, her temperature was 96.81F, pulse 80, respiratory rate 20, and her blood pressure was 117/65. A urine toxicology screen, in addition to CBC, SMA-7, TSH, ANA, ds DNA, and anti-Sm Ab, was within normal limits. After consultation with Neonatalology and Pediatric Cardiology, the decision was made to attempt to convert the fetal tachycardia with maternal administration of digoxin. The patient received 0.5 mg i.v. loading dose followed by 0.25 mg i.v. every 4 hours. After 24 hours with no change in the fetal heart rate, the decision was made for delivery with treatment to the neonate as indicated.
The fetal heart rate remained in the 230 bpm range during her induction. After 12 hours of labor, she underwent a cesarean section for failure to progress. She was delivered of a viable female infant with Apgar scores of 6 and 9 at 1 and 5 minutes, respectively. The infant weighed 3580 g. The umbilical artery blood gas was pH 7.35 with a Base excess of À3.3 meq/l.
At delivery, the infant initially had a heart rate of less than 100 bpm. After drying, suctioning, and stimulation, the ventricular rate rapidly rose to about 230 bpm with 2:1 block and remained persistently elevated. There was no clinical evidence of heart failure. However, because of the persistence of atrial flutter, the neonate underwent transesophageal incremental overdrive pacing. This was accomplished by successfully capturing and interrupting the arrhythmia at cycle length of 118 milliseconds (500 bpm).
There was no further recurrence of atrial flutter. No antiarrythmic drugs were employed for the neonate. Follow-up evaluation at 6 months of age was uneventful. The infant's heart rate and physical exam were unremarkable and appropriate for age.
DISCUSSION
Fetal tachyarrhythmias are uncommonly encountered, but have the potential for serious sequalae for both fetus and neonate. There are three major groups of fetal tachyarrhythmias: atrial flutter/ fibrillation, supraventricular tachycardia, and multifocal atrial extrasystoles. 1 Sustained tachyarrhythmias can result in a fetal high cardiac output failure state seen as, fetal hydrops.
The differential diagnosis includes sinus tachycardia. Sinus tachycardias occur commonly in utero. Although the heart rate is substantially lower than with the supraventricular 
Gimovsky et al.
Fetal/Neonatal Supraventricular Tachycardia tachyarrhythmias, their presence may impede the timely recognition of the potentially more serious tachyarrhythmias. Fetal sinus tachycardia may be seen with or without maternal sinus tachycardia. Fetal sinus tachycardia occurs with maternal fever, maternal drug use, maternal hyperthyroidism, and with either maternal or fetal infections. Fetal sinus tachycardia may also be seen with fetal hypoxemia. Under this circumstance, the FHR pattern usually manifests diminished beat to beat variability with periodic decelerations. Fetal tacharrythmias that are supraventricular in origin are generally considered manifestations of intrinsic cardiac pathology. An increase in firing of an ectopic pacemaker, or a re-entry phenomenon at or above the AV node results in a rapid ventricular response rate. With Wolff-Parkinson-White syndrome, the additional atrial pacing is conducted by an accessory conduction pathway. Differences in refractory periods and conduction velocities are the pathophysiologic basis of the aberrant conduction.
With atrial flutter or fibrillation, a functional AV block results in varying ventricular response rates. Maternal treatment with type I antiarrhythmics has been employed for conversion, but with limited response noted in utero. 2 In the case of NF's infant, no ultrasound evidence was present to suggest fetal hydrops. Thus, the initial decision was made to treat with maternal administration of digoxin. With a fetus at term and a reassuring biophysical profile, the decision was to induce labor. The patient failed to progress in labor and a primary cesarean section was performed for that specific indication.
The neonate remained in sustained atrial flutter. There were no signs of heart failure or any clinical compromise.
Normal sinus rhythm was successfully achieved on the first day of life by transesophageal atrial overdrive pacing. Overdrive atrial pacing is only successful in 50% of the cases. Other treatment modalities include various antiarrythmic agents. Transvenous cardiac pacing, cardioversion, and radioablation have all been described, with varying degree of success. 3, 4 Routine prenatal care allows for screening of common maternal and fetal disorders. The recognition and subsequent evaluation of the fetal tachycardia ultimately led to diagnosis and prompt intervention. This resulted in an optimal outcome for the neonate.
